Moser, Monika; Radu, Iuliana-Pompilia; Dufour, Jean-François (2021). Effects of Home Care on patients with hepatocellular carcinoma treated with sorafenib. JGH open, 5(8), pp. 864-870. Wiley 10.1002/jgh3.12533
|
Text
JGH3-5-864.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC). Download (292kB) | Preview |
Background and Aim
Treatment with sorafenib causes diverse side effects, which limits adherence. This work assesses whether Home Care, a psychosocial nursing intervention, prolongs the duration of treatment in patients with advanced hepatocellular carcinoma (HCC) and if it influences health-related quality of life (HRQL).
Methods and Results
This is a cohort study using data from patients receiving sorafenib in the prospective Bern HCC Cohort at the University Hospital. Duration of treatment, overall survival, and HRQL using the Functional Assessment of Cancer Therapy-Hepatobiliary questionnaire were compared in the two groups. A total of 173 patients were eligible for the analysis. Among them, 141 were in the Home Care program, and 32 were not. Patients with Home Care had a significantly longer duration of treatment (265 days vs 152 days, P = 0.003) and a better functional well-being (17.7 vs 12.5, P = 0.015).
Conclusion
Psychosocial interventions such as Home Care are a valid method in improving adherence to sorafenib and can therefore be recommended.
Actions (login required)
 |
Edit item |